Structural basis for ligand reception by anaplastic lymphoma kinase
- Research Organization:
- Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
- Sponsoring Organization:
- DOE - Office Of Science; NIGMS; National Institutes of Health (NIH)
- OSTI ID:
- 1863995
- Journal Information:
- Nature, Vol. 600
- Country of Publication:
- United States
- Language:
- ENGLISH
Similar Records
Structural basis for ligand reception by anaplastic lymphoma kinase
basis for ligand reception by anaplastic lymphoma kinase
Structure Based Drug Design of Crizotinib (PF-02341066), a Potent and Selective Dual Inhibitor of Mesenchymal-Epithelial Transition Factor (c-MET) Kinase and Anaplastic Lymphoma Kinase (ALK)
Journal Article
·
2021
· Nature
·
OSTI ID:1844774
+15 more
basis for ligand reception by anaplastic lymphoma kinase
Journal Article
·
2021
· Nature
·
OSTI ID:1834834
+15 more
Structure Based Drug Design of Crizotinib (PF-02341066), a Potent and Selective Dual Inhibitor of Mesenchymal-Epithelial Transition Factor (c-MET) Kinase and Anaplastic Lymphoma Kinase (ALK)
Journal Article
·
2011
· Journal of Medicinal Chemistry
·
OSTI ID:1064493
+22 more